Latest Series A Funding Rounds
Companies raising their first major institutional growth round, from the product they sell to the investors backing their next stage.
- Rounds
- 1,140 All time
- Disclosed funding
- $47.7B 980 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| M MotifCompany profile A browser-based platform for building design, model collaboration and AI-assisted architecture workflows. A browser-based platform for building design, model collaboration and AI-assisted architecture workflows. | Undisclosed | Series A | Proptech | United States | Investors | |
NabooCompany profile Naboo helps companies source, book and pay for corporate events through one supplier and a shared procurement platform. Naboo helps companies source, book and pay for corporate events through one supplier and a shared procurement platform. | €20M | Series A | Business services | France | Investors | |
| MA Music AICompany profile Music AI builds audio-processing tools for music businesses and developers, alongside the Moises app for musicians. Music AI builds audio-processing tools for music businesses and developers, alongside the Moises app for musicians. | $30M | Series A (primary financing)Series A | Media & gaming | United States | Investors | |
| AT Arctic TherapeuticsCompany profile Arctic Therapeutics develops treatments for neurological, autoimmune and inflammatory skin diseases using insights from human genetics. Arctic Therapeutics develops treatments for neurological, autoimmune and inflammatory skin diseases using insights from human genetics. | €26.5M | Series A | Biotech | Iceland | Investors | |
| BE Bedrock EnergyCompany profile Geothermal drilling and subsurface design for building heating and cooling. Geothermal drilling and subsurface design for building heating and cooling. | $12M | Series A | Climate tech | United States | Investors | |
KardiganCompany profile Kardigan develops cardiovascular medicines that target specific biological drivers of heart disease and the patient groups most likely to respond. Kardigan develops cardiovascular medicines that target specific biological drivers of heart disease and the patient groups most likely to respond. | $300M | Series A | Biotech | United States | Investors | |
| H HyperbolicCompany profile Hyperbolic provides GPU cloud infrastructure and software for deploying AI workloads across multiple compute providers. Hyperbolic provides GPU cloud infrastructure and software for deploying AI workloads across multiple compute providers. | $12M | Series A | AI | United States | Investors | |
NscaleCompany profile Provides vertically integrated AI infrastructure for enterprise AI training, fine-tuning, and inference Provides vertically integrated AI infrastructure for enterprise AI training, fine-tuning, and inference | $155M | Series A convertible notesSeries A | AI | United Kingdom | Investors | |
BoldfitCompany profile Boldfit sells sportswear, footwear and fitness equipment for people training at home, in gyms and on the court. Boldfit sells sportswear, footwear and fitness equipment for people training at home, in gyms and on the court. | ₹1.1B | Series A | Consumer | India | Investors | |
YazenCompany profile Yazen provides digital obesity care through a clinical team, medical treatment and ongoing lifestyle support. Yazen provides digital obesity care through a clinical team, medical treatment and ongoing lifestyle support. | €19.5M | Series A | Healthtech | Sweden | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Y Combinator (YC)
Palomma, Easol, Vera Health
56rounds0led - 2Andreessen Horowitz (a16z)
Larridin, Eka Robotics, TypeSafe AI
35rounds10led - 3General Catalyst
Onodrim Industries, Hyperbolic, Baba
28rounds2led - 4Accel
Humyn Labs, Dreamteam, SE3
25rounds8led - 5Alumni Ventures
Larridin, Chariot Claims, RegCell, Inc.
24rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.